AI Verdict
ZTS has stronger fundamentals based on our AI analysis.
CVS vs ZTS Fundamental Comparison
| Metric | CVS | ZTS |
|---|---|---|
| Revenue | $402.1B | $9.5B |
| Net Income | $1.8B | $2.7B |
| Net Margin | 0.4% | 28.2% |
| ROE | 2.4% | 80.2% |
| ROA | 0.7% | 17.3% |
| Current Ratio | 0.84x | 3.03x |
| Debt/Equity | 0.85x | 2.71x |
| EPS | $1.39 | $6.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CVS vs ZTS: Frequently Asked Questions
Is CVS or ZTS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ZTS has stronger fundamentals. CVS is rated HOLD (70% confidence) while ZTS is rated BUY (78% confidence). This is not investment advice.
How does CVS compare to ZTS fundamentally?
CVS HEALTH Corp has ROE of 2.4% vs Zoetis Inc.'s 80.2%. Net margins are 0.4% vs 28.2% respectively.
Which stock pays higher dividends, CVS or ZTS?
CVS has a dividend yield of N/A or no dividend while ZTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CVS or ZTS for long term?
For long-term investing, consider that CVS has HOLD rating with 70% confidence, while ZTS has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CVS vs ZTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CVS vs ZTS, the AI consensus favors ZTS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.